
Alpha Profiles · Company Profile
XBiotech Inc.
XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies.
https://registry.alpha.ac/companies/xbiotech-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: XBIT
- Verification
- Partially verified
- Last reviewed
- 2026-10-13T04:46:55.172188+00:00
Overview
XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline of product candidates aimed at combating both inflammatory and infectious diseases. Furthermore, the company is advancing interleukin-1 alpha-based therapies, which are designed to address a broad spectrum of medical conditions such as cancer, stroke, heart attack, and arthritis.
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-13T04:46:55.172188+00:00
